Mitoxantrone and marrow hyperplasia Patient Reports February 12, 2012
Mitoxantrone Side Effects Report #5751459-9
Mitoxantrone side effect was reported by a Physician from UNITED STATES on May 15, 2008. Male patient, 51 years of age, was diagnosed with multiple sclerosis
and was treated with Mitoxantrone. After drug was administered, patient experienced the following side effects: acute promyelocytic leukaemia, cellulitis
, marrow hyperplasia, pancytopenia. Mitoxantrone dosage: unknown. Patient recovered.Mitoxantrone Side Effects Report #5751458-7
Mitoxantrone side effect was reported by a Health Professional from UNITED STATES on May 15, 2008. Female patient, 48 years of age, was diagnosed with multiple sclerosis
and was treated with Mitoxantrone. After drug was administered, patient experienced the following side effects: acute promyelocytic leukaemia, marrow hyperplasia, pancytopenia. Mitoxantrone dosage: 12 MG/M2OTH. Patient recovered.Mitoxantrone Side Effects Report #5232288-1
Mitoxantrone side effect was reported by a Consumer or non-health professional from ITALY on Jan 23, 2007. Female patient, 21 years of age, was diagnosed with multiple sclerosis
and was treated with Mitoxantrone. After drug was administered, patient experienced the following side effects: acute promyelocytic leukaemia, disseminated intravascular coagulation, fatigue, gingival bleeding, hepatosplenomegaly, hyperhidrosis, marrow hyperplasia. Mitoxantrone dosage: unknown. During the same period patient was treated with INTERFERON BETA. Patient recovered.Mitoxantrone Side Effects Report #5756836-8
Mitoxantrone side effect was reported by a Consumer or non-health professional from UNITED STATES on May 13, 2008. Female patient was diagnosed with multiple sclerosis
and was treated with Mitoxantrone. After drug was administered, patient experienced the following side effects: acute myeloid leukaemia, blast cell crisis, blood alkaline phosphatase increased, chronic myeloid leukaemia, marrow hyperplasia, thrombocythaemia, urinary tract infection
. Mitoxantrone dosage: 18 MG, 1 IN 2 MONTHS. During the same period patient was treated with AVONEX. Patient recovered.
Mitoxantrone and marrow hyperplasia 